NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • May 12th, 2022 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 12th, 2022 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Cingulate Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Cingulate Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENT DERMATA THERAPEUTICS, INC.Nonqualified Stock Option Grant Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 10th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
VYANT BIO, INC. 2020 STOCK INCENTIVE PLANNonqualified Stock Option Grant Agreement • April 5th, 2021 • Vyant Bio, Inc. • Services-medical laboratories • Delaware
Contract Type FiledApril 5th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Vyant Bio, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • March 23rd, 2021 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 23rd, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Timber Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENT REVIVA PHARMACEUTICALS HOLDINGS, INC.Nonqualified Stock Option Grant Agreement • December 18th, 2020 • Reviva Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 18th, 2020 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Reviva Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • May 15th, 2018 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledMay 15th, 2018 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • January 5th, 2018 • Motus GI Holdings, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledJanuary 5th, 2018 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Motus GI Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • April 12th, 2017 • Motus GI Holdings, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledApril 12th, 2017 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Motus GI Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • November 3rd, 2016 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 3rd, 2016 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Adgero Biopharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENT PROTAGENIC THERAPEUTICS, INC.Nonqualified Stock Option Grant Agreement • June 20th, 2016 • Atrinsic, Inc. • Services-business services, nec • Delaware
Contract Type FiledJune 20th, 2016 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Protagenic Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENT MATINAS BIOPHARMA HOLDINGS, INC.Nonqualified Stock Option Grant Agreement • February 7th, 2014 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledFebruary 7th, 2014 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Matinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).